FIBROGEN INC's ticker is FGEN and the CUSIP is 31572Q808. A total of 217 filers reported holding FIBROGEN INC in Q4 2019. The put-call ratio across all filers is 0.60 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $1,000 | 0.0% | 20 | 0.0% | 0.00% | – |
| Q4 2021 | $1,000 | 0.0% | 20 | -41.2% | 0.00% | – |
| Q3 2021 | $1,000 | – | 34 | – | 0.00% | – |
| Q2 2021 | $0 | -100.0% | 0 | -100.0% | 0.00% | -100.0% |
| Q1 2021 | $45,000 | +12.5% | 1,335 | +13.9% | 0.00% | -50.0% |
| Q4 2020 | $40,000 | -44.4% | 1,172 | -33.3% | 0.00% | -50.0% |
| Q3 2020 | $72,000 | +20.0% | 1,756 | +18.4% | 0.00% | -20.0% |
| Q2 2020 | $60,000 | +20.0% | 1,483 | +1.3% | 0.01% | 0.0% |
| Q1 2020 | $50,000 | -24.2% | 1,464 | +2.2% | 0.01% | 0.0% |
| Q4 2019 | $66,000 | +10.0% | 1,433 | -5.8% | 0.01% | +25.0% |
| Q3 2019 | $60,000 | – | 1,521 | +25250.0% | 0.00% | – |
| Q4 2018 | $0 | – | 6 | 0.0% | 0.00% | – |
| Q3 2018 | $0 | -100.0% | 6 | -76.0% | 0.00% | – |
| Q2 2018 | $2,000 | – | 25 | +316.7% | 0.00% | – |
| Q1 2018 | $0 | – | 6 | 0.0% | 0.00% | – |
| Q4 2017 | $0 | – | 6 | 0.0% | 0.00% | – |
| Q3 2017 | $0 | – | 6 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Vantage Consulting Group Inc | 605,713 | $9,703,522 | 5.73% |
| ARMISTICE CAPITAL, LLC | 3,864,000 | $61,901,280 | 1.08% |
| Logos Global Management LP | 525,000 | $8,410,500 | 0.98% |
| 5AM Venture Management, LLC | 225,583 | $3,613,840 | 0.97% |
| Intercontinental Wealth Advisors, LLC | 191,300 | $3,064,626 | 0.91% |
| BHK Investment Advisors, LLC | 87,550 | $1,402,551 | 0.79% |
| Integral Health Asset Management, LLC | 175,000 | $2,803,500 | 0.59% |
| Nan Fung Group Holdings Ltd | 34,106 | $546,378 | 0.38% |
| Soleus Capital Management, L.P. | 113,463 | $1,817,677 | 0.26% |
| Point72 Asset Management, L.P. | 4,781,645 | $76,601,953 | 0.26% |